Amenamevir

Sibling codes

• XM01X3 – Letermovir
• XM1EQ6 – Enfuvirtide
• XM1KL9 – Cobicistat
• XM1R42 – Ibacitabine
• XM1UC2 – Tilorone
• XM23V6 – Pleconaril
• XM2KW1 – Ibalizumab
• XM2L29 – Favipiravir
• XM3EZ0 – Nucleoside and nucleotide reverse transcriptase inhibitors
• XM3FG0 – Maraviroc
• XM3S98 – Umifenovir
• XM3SJ3 – Antivirals for treatment of hepatitis C infections, combinations
• XM3U67 – Antivirals for treatment of human immunodeficiency virus infections, combinations
• XM56B8 – Nucleosides and nucleotides
• XM5GV1 – Moroxydine
• XM5PT4 – Non-nucleoside reverse transcriptase inhibitors
• XM60K5 – Lysozyme
• XM63K0 – Anti-infective antiviral
• XM6CJ2 – Fosfonet sodium
• XM6DT0 – Neuraminidase inhibitors
• XM6K45 – Dolutegravir
• XM6SP8 – Metisazone
• XM6WB2 – Trifluridine
• XM7FP8 – Tecovirimat
• XM7HJ6 – Maribavir
• XM7QR0 – Cyclic amines
• XM7SG2 – Dideoxyinosine
• XM7WY9 – Elvitegravir
• XM82D3 – Raltegravir
• XM85A9 – Lenacapavir
• XM8AQ1 – Inosine pranobex
• XM8CN1 – Enisamium iodide
• XM8GK2 – Protease inhibitors
• XM90G3 – Phosphonic acid derivatives
• XM90X2 – Pentanedioic acid imidazolyl ethanamide
• XM9A16 – Baloxavir marboxil
• XM9DH8 – Antivirals for treatment of hepatitis C infections
• XM9VL0 – Foscarnet sodium

Foundation entity

Amenamevir – http://id.who.int/icd/entity/375604445